Tryptase
Note: this site is for informational purposes only. To view test results or book a test, use the NHS app in England or contact your GP.
The tryptase test is a blood test in which a sample is taken from a vein to measure the level of tryptase, an enzyme released from mast cells during allergic reactions. It is used to help confirm anaphylaxis and to diagnose or monitor mast cell disorders, such as mastocytosis.
Why get tested?
To help diagnose anaphylaxis, mastocytosis (too many abnormal mast cells), or mast cell activation syndrome
When to get tested?
When you have symptoms such as flushing, nausea, throat swelling, or low blood pressure that may be due to a life-threatening allergic reaction; when your healthcare professional suspects that you have mastocytosis or mast cell activation syndrome.
Sample required?
A blood sample taken from a vein in your arm
Test preparation needed?
None, but timing of the sample soon after the beginning of symptoms can be important.
What is being tested?
Tryptase is an enzyme that is released, along with histamine and other chemicals, from mast cells when they are activated as part of a normal immune response as well as in allergic (hypersensitivity) responses. This test measures the amount of tryptase in the blood.
Mast cells are immune cells resident in tissues throughout the body. They are present in highest amounts in the skin, the lining of the intestine and air passages, and the bone marrow. They contain granules that store a number of chemicals, including tryptase and histamine. When mast cells are activated, they release their contents. If a person has clumps of abnormal mast cells (mastocytosis) and/or the cells are activated inappropriately, the chemicals that are released (especially histamine) may cause symptoms that range from moderate to life-threatening.
Normally, the level of tryptase in the blood is very low. When mast cells are activated, the level increases rapidly, rising within 15 to 30 minutes, peaking at 1 to 2 hours, and returning to normal after several hours to a couple of days. In people with severe allergies, activation of many mast cells can cause an extreme form of allergic reaction known as anaphylaxis, which can cause low blood pressure, hives (nettle rash or blisters on the skin), severe narrowing of the air passages, and even death. Tryptase levels will be very high in people with anaphylaxis.
In some cases, tryptase levels will be high in persons with mast cell activation disorders, in which mast cells become activated without apparent allergies or other reasons.
Tryptase levels can also be significantly and persistently increased with mastocytosis, a rare group of disorders associated with an abnormal increase in the number of mast cells. These cells may accumulate in the skin (cutaneous mastocytosis) or in organs throughout the body (systemic mastocytosis).
While cutaneous mastocytosis typically only causes skin problems (particularly hives), people with systemic mastocytosis may experience anaphylaxis and its associated symptoms and are at especially high risk of anaphylaxis with venoms (e.g. Bee or Wasp). These symptoms may be persistent and are related to the organs affected by mast cell accumulation. Systemic mastocytosis may progress slowly or may be aggressive, causing organ dysfunction and, in rare cases, causing a form of leukaemia.
Common questions
The tryptase test is a useful indicator of mast cell activation and number. Mast cells are immune cells present in highest amounts in the skin, the lining of the intestine and air passages, and the bone marrow. They release tryptase and other substances as part of the body’s normal response to injury or parasite infection but also may release them as part of an allergic response. The tryptase test may be used:
- To confirm a diagnosis of anaphylaxis. Anaphylaxis is primarily diagnosed clinically, but a total tryptase should be requested, to help confirm anaphylaxis as the cause of someone’s acute symptoms. This is especially true if the person has recurrent episodes and/or if the diagnosis is uncertain.
- To help diagnose mastocytosis (too many mast cells) or a mast cell activation disorder. Mastocytosis is a rare group of disorders associated with an abnormal increase in the number of mast cells, which may accumulate in the skin (cutaneous mastocytosis) or in organs throughout the body (systemic mastocytosis).
Other tests may be used to evaluate a person’s health status and to help rule out other conditions that can cause similar symptoms. These may include:
- Allergen-specific IgE blood tests to help determine the cause of an allergic reaction
- Full Blood Count (FBC) to evaluate red and white blood cells
- Renal, liver and thyroid function tests, plus bone profile to evaluate organ function
- 5‑hydroxyindoleacetic acid (5‑HIAA) urine test to rule out a carcinoid tumour that may cause similar symptoms, such as flushing, diarrhoea, and/or wheezing
- Gastrin test to look for increased secretion of this hormone, which may cause stomach or intestinal ulcers
Occasionally, a tryptase test may be performed postmortem to help determine if anaphylaxis was the cause of a person’s death.
Tryptase is not a frequently requested test. The NICE guidelines for the management of suspected anaphylaxis state that a tryptase series of blood tests should be sent to the laboratory for testing in all cases. Mastocytosis is rare. Symptoms of anaphylaxis may include:
- Flushing
- Swelling of the throat, face, tongue, and/or eyes
- Low blood pressure
- Nausea, vomiting, diarrhoea, abdominal pain
- Cardiac arrhythmias
- Light-headedness or dizziness
- Difficulty breathing, wheezing
- Itching, often with visible hives
- Confusion and/or loss of consciousness
Many of these symptoms are also seen with other conditions.
This test may also be requested when a healthcare professional suspects that a person may have cutaneous or systemic mastocytosis or a mast cell activation disorder. People with such conditions may have many of the same symptoms and signs as people with severe allergies but often without any specific trigger, such as exposure to a specific food (such as peanuts) or a bee sting. People with systemic mastocytosis may have symptoms that indicate organ involvement, such as peptic ulcers, chronic diarrhoea, and joint pain. There may be enlargement of organs such as the liver, spleen, or lymph nodes. There may be skin involvement with rashes or characteristic red, blistering lesions.
A tryptase test may be requested after a person’s death to help determine if anaphylaxis was the cause of death.
Normal tryptase results may indicate that a person’s symptoms are not due to mast cell activation, or there could be a problem with sample timing. With anaphylaxis, tryptase concentrations typically peak about 1 to 2 hours after symptoms begin. If a sample is drawn too early or late, results may be normal. If a histamine test is also performed, it can be compared to the tryptase levels. Histamine concentrations peak within several minutes of the onset of anaphylaxis and fall within about an hour. If the timing of sample collection was appropriate and neither the histamine or tryptase concentrations are elevated, it is unlikely that a person had anaphylaxis, but it cannot be ruled out.
Acutely elevated tryptase concentrations in a person with symptoms of anaphylaxis indicate it as the likely diagnosis. A baseline sample for comparison is always required.
Persistently elevated tryptase concentrations in a person with symptoms of mast cell activation suggest that the person may have mastocytosis. Additional testing is required to confirm this diagnosis. Tryptase concentrations are thought to correlate with mast cell “burden” (quantity) in those with systemic mastocytosis.
If systemic mastocytosis is suspected, an elevated tryptase test result may be followed by a bone marrow aspiration and biopsy to determine if systemic mastocytosis is present. Typically, there are clusters of increased numbers of mast cells in the bone marrow in this disease.
Tryptase can also be elevated with asthma, myelodysplastic syndrome (a type of bone marrow disorder), acute myelocytic leukaemia, and with any condition that activates mast cells.
The release of tryptase from mast cells may be triggered by a wide variety of substances, but reaction to a food is thought to be the most common cause of anaphylaxis.
Anyone can have mastocytosis, but children are more frequently affected with cutaneous mastocytosis. In children, mastocytosis is more likely to be self-limited and may be transient.
Studies have linked genetic mutations with some cases of systemic mastocytosis. One of the common mutations identified is a codon-816 C‑KIT mutation (CD117). Testing for this mutation is not routine but may occasionally be performed.
No, the tryptase test is a specialised blood test that is not offered in every laboratory and the sample will usually be sent to a reference laboratory for testing.
Your healthcare professional may request specific allergy tests to help determine the substances you are allergic to, but a tryptase test would usually be done only if severe allergic symptoms are present. Most people with allergies will never need to have a tryptase test performed.
Anaphylaxis can be rapidly fatal and requires immediate medical treatment with injections of epinephrine and other medications. This is followed by careful monitoring as it is not uncommon for anaphylaxis to recur within hours or days of the initial episode. Those who are known to have severe allergic reactions are encouraged to carry a kit that contains an emergency injection of epinephrine with them at all times.
Not necessarily. Tryptase is just one of the criteria that your healthcare professional will consider before making a diagnosis of mastocytosis, which is a rare disorder. Patients who are rheumatoid factor positive can have a falsely elevated tryptase result. Not all tests are affected by this, so discuss with your healthcare professional.